Literature DB >> 21592118

Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES).

Marjorie A Illingworth1, Donncha Hanrahan, Claire E Anderson, Kathryn O'Kane, Jennifer Anderson, Maureen Casey, Carlos de Sousa, J Helen Cross, Sukvhir Wright, Russell C Dale, Angela Vincent, Manju A Kurian.   

Abstract

Fever-induced refractory epileptic encephalopathy in school-age children (FIRES) is a clinically recognized epileptic encephalopathy of unknown aetiology. Presentation in previously healthy children is characterized by febrile status epilepticus. A pharmacoresistant epilepsy ensues, occurring in parallel with dramatic cognitive decline and behavioural difficulties. We describe a case of FIRES in a 4-year-old boy that was associated with elevated voltage-gated potassium channel (VGKC) complex antibodies and a significant clinical and immunological response to immunomodulation. This case, therefore, potentially expands the clinical phenotype of VGKC antibody-associated disease to include that of FIRES. Prior to immunomodulation, neuropsychology assessment highlighted significant attention, memory, and word-finding difficulties. The UK version of the Wechsler Preschool and Primary Scale of Intelligence assessment indicated particular difficulties with verbal skills (9th centile). Immunomodulation was initially administered as intravenous methylprednisolone (followed by maintenance oral prednisolone) and later in the disease course as regular monthly intravenous immunoglobulin infusions and low-dose azathioprine. Now aged 6 years, the seizure burden in this child is much reduced, although increased seizure frequency is observed in the few days before his monthly immunoglobulin infusions. Formal IQ assessment has not been repeated but there is no clinical suggestion of further cognitive regression. VGKC complex antibodies have been reported in a range of central and peripheral neurological disorders (predominantly presenting in adulthood), and the identification of elevated VGKC complex antibodies, combined with the response to immunotherapies in this child, supports an autoimmune pathogenesis in FIRES with potential diagnostic and therapeutic implications. © The Authors. Developmental Medicine & Child Neurology
© 2011 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592118     DOI: 10.1111/j.1469-8749.2011.04008.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

Review 1.  Autoimmune encephalitis and its relation to infection.

Authors:  Arun Venkatesan; David R Benavides
Journal:  Curr Neurol Neurosci Rep       Date:  2015-03       Impact factor: 5.081

2.  Clinical relevance of voltage-gated potassium channel–complex antibodies in children.

Authors:  Yael Hacohen; Rahul Singh; Meghan Rossi; Bethan Lang; Cheryl Hemingway; Ming Lim; Angela Vincent
Journal:  Neurology       Date:  2015-09-15       Impact factor: 9.910

3.  Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis.

Authors:  Divyanshu Dubey; Zehra Farzal; Ryan Hays; L Steven Brown; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2016-07-04       Impact factor: 6.570

4.  Febrile infection-related epilepsy syndrome treated with anakinra.

Authors:  Daniel L Kenney-Jung; Annamaria Vezzani; Robert J Kahoud; Reghann G LaFrance-Corey; Mai-Lan Ho; Theresa Wampler Muskardin; Elaine C Wirrell; Charles L Howe; Eric T Payne
Journal:  Ann Neurol       Date:  2016-11-14       Impact factor: 10.422

Review 5.  Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.

Authors:  M T Montojo; M Petit-Pedrol; F Graus; J Dalmau
Journal:  Neurologia       Date:  2014-01-30       Impact factor: 3.109

Review 6.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

Review 7.  The challenges and innovations for therapy in children with epilepsy.

Authors:  Jo M Wilmshurst; Anne T Berg; Lieven Lagae; Charles R Newton; J Helen Cross
Journal:  Nat Rev Neurol       Date:  2014-04-08       Impact factor: 42.937

8.  Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures.

Authors:  Deepa Sirsi; Alison Dolce; Benjamin M Greenberg; Drew Thodeson
Journal:  Ann Clin Case Rep       Date:  2016-11-03

9.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

10.  Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

Authors:  Yael Hacohen; Sukhvir Wright; Patrick Waters; Shakti Agrawal; Lucinda Carr; Helen Cross; Carlos De Sousa; Catherine Devile; Penny Fallon; Rajat Gupta; Tammy Hedderly; Elaine Hughes; Tim Kerr; Karine Lascelles; Jean-Pierre Lin; Sunny Philip; Keith Pohl; Prab Prabahkar; Martin Smith; Ruth Williams; Antonia Clarke; Cheryl Hemingway; Evangeline Wassmer; Angela Vincent; Ming J Lim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-22       Impact factor: 13.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.